Companies House · 06751069

IPSEN LIMITED

UK registered company, private limited company, incorporated 17 Nov 2008.

Active
50
Public contracts
0
Spend payments
Total spend

IPSEN LIMITED is a UK company registered at Companies House under number 06751069. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
06751069
Status
Active
Company type
Private Limited Company
Incorporated
17 Nov 2008
Country of origin
United Kingdom
Registered office
5TH FLOOR THE POINT, LONDON, W2 1AF, UNITED KINGDOM
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to IPSEN LIMITED.

ProcurementBuyerAwardedValue
Gonadorelin AnaloguesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS Framework for North of England Branded Medicines - Tranche A and Annual TrancheNHS England
NHS Framework for Midlands and East Branded Medicines - Tranche B and Annual TrancheNHS England
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
Triptorelin (Decapeptyl®)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Triptorelin (Decapeptyl®)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP39724 Generic and Biosimilar Cancer MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gonadorelin AnaloguesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gonadorelin AnaloguesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
Proprietary DrugseTenderwales
Proprietary DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Oncology Generics MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
NHS Framework Agreement for Branded Medicines - NationalNHS England26 Sept 2021£95.2m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework, North of England, Branded Medicines-Tranche A and Annual TrancheNHS England11 Feb 2021£1
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS Framework for the NHS London Region, Branded Medicines - Tranche ANHS England16 Jun 2020£191.1m
NHS Framework Agreement - North of England - Tranche BNHS England13 Feb 2020£205.5m
NHS Midlands and East Branded Medicines - Tranche ANHS England15 Jan 2020£418.8m
NHS South of England Branded Medicines - Tranche ANHS England31 Jul 2019£188m
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder OpportunityNHS England4 Jul 2019£251.9m

Supplier identities

How this company appears as a supplier across the data.

FAQs about IPSEN LIMITED

Is IPSEN LIMITED an active company?

IPSEN LIMITED (company number 06751069) is recorded as "Active", incorporated on 17 Nov 2008.

What does IPSEN LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has IPSEN LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is IPSEN LIMITED based?

Its registered office is 5TH FLOOR THE POINT, LONDON, W2 1AF, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable